JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 86 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.97 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,000 | -33.3% | 2,358 | -59.7% | 0.00% | – |
Q4 2022 | $6,000 | +500.0% | 5,852 | +1040.7% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 513 | +116.5% | 0.00% | – |
Q2 2022 | $1,000 | -93.8% | 237 | -89.8% | 0.00% | – |
Q1 2022 | $16,000 | -72.4% | 2,325 | -66.1% | 0.00% | – |
Q4 2021 | $58,000 | +70.6% | 6,865 | +51.4% | 0.00% | – |
Q3 2021 | $34,000 | +100.0% | 4,533 | +77.2% | 0.00% | – |
Q2 2021 | $17,000 | -26.1% | 2,558 | +12.0% | 0.00% | – |
Q1 2021 | $23,000 | +228.6% | 2,283 | +133.2% | 0.00% | – |
Q4 2020 | $7,000 | +250.0% | 979 | +226.3% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | -80.0% | 300 | -86.0% | 0.00% | – |
Q1 2020 | $10,000 | -16.7% | 2,149 | +59.9% | 0.00% | – |
Q4 2019 | $12,000 | +1100.0% | 1,344 | +348.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -75.0% | 300 | -51.3% | 0.00% | – |
Q3 2018 | $4,000 | -33.3% | 616 | -25.0% | 0.00% | – |
Q2 2018 | $6,000 | -85.0% | 821 | -54.4% | 0.00% | – |
Q1 2018 | $40,000 | +700.0% | 1,800 | +418.7% | 0.00% | – |
Q4 2017 | $5,000 | -76.2% | 347 | -74.0% | 0.00% | – |
Q3 2017 | $21,000 | +2000.0% | 1,337 | +1571.2% | 0.00% | – |
Q2 2017 | $1,000 | -88.9% | 80 | -80.0% | 0.00% | – |
Q1 2017 | $9,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|